Exiqon A/S Launches New Products for the Research and Development of LNA(TM) Based Drugs
VEDBAEK, Denmark, Oct. 10, 2011 (GLOBE NEWSWIRE) -- Exiqon A/S (Copenhagen:EXQ), a leading supplier of high-value products for gene expression analysis, today announced the expansion of its product offering to include LNA tm products for the research and development of RNA targeted medicine including LNA tm as the active pharmaceutical ingredient.